2-溴乙醇 、 3-(2-Hydroxy-ethoxy)-4-isopropoxy-benzaldehyde 以from 3-hydroxy-4-isopropoxybenzaldehyde (prepared in 75% yield by monoalkylation of 3,4-dihydroxybenzaldehyde with isopropyl bromide and K2CO3 in DMF) and 2-bromo-ethanol there was obtained 3-(2-hydroxy-ethoxy)-4-isopropoxy-benzaldehyde, which的产率得到3-羟基-4-异丙氧基-苯甲醛
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
申请人:Binggeli Alfred
公开号:US20060205718A1
公开(公告)日:2006-09-14
This invention is concerned with compounds of the formula
wherein A, B
1
, B
2
, R
1
, R
2
and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
The invention is concerned with novel N-(4-carbamimidoyl-phenyl)-glycine derivatives of the formula:
1
wherein R
1
, E, X
1
to X
4
and G
1
and G
2
are as defined in the description and the claims, as well as hydrates or solvates and physiologically usable salts thereof.